Enterprise

Sophia Genetics

SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the SOPHiA universal Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach helps encourage the sharing of knowledge through an ever-expanding partner network of nearly 1’000 institutions, creating the world’s first collective intelligence for healthcare. 

The company's achievements and innovative approach are recognized by The MIT Technology Review's "50 Smartest Companies 2017".